InBody Co.,Ltd
KOE: 041830.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Ki-Chul Cha
- Employees
- 266
- Headquarters
- Seoul, South Korea
- IPO year
- 2000
- Market cap
- ₩469.4B
- Website
- https://www.inbody.com/global
Loading 041830…
Loading profile data…Frequently asked questions about 041830
What does InBody Co.,Ltd (041830.KQ) do?
InBody Co.,Ltd provides body composition analysis solutions worldwide. The company offers body composition analyzers, blood pressure monitors, stadiometers, and body water analyzers, as well as InBody dial and bands. Its products are used in nephrology, liver disease, diabetes, nutrition, and rehabilitation applications. The company was formerly...
Where does 041830.KQ trade?
InBody Co.,Ltd (041830.KQ) trades on the KOSDAQ.
What sector is 041830.KQ in?
InBody Co.,Ltd (041830.KQ) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of InBody Co.,Ltd?
Ki-Chul Cha is the chief executive officer of InBody Co.,Ltd (041830.KQ).
Where is InBody Co.,Ltd headquartered?
InBody Co.,Ltd is headquartered in South Korea.
Does 041830.KQ pay a dividend?
Yes — InBody Co.,Ltd (041830.KQ) paid a trailing twelve-month dividend of KRW 600.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 041830.KQ go public?
InBody Co.,Ltd (041830.KQ) completed its initial public offering in 2000.